Excellence in innovation

During the past decade, Rowan University has rapidly transformed into a top 100 public research institution and the third fastest-growing public research university in the nation. In 2018, the University earned classification as a Carnegie R2 doctoral university (high research activity).

Research has been funded by the National Institutes of Health, National Science Foundation, and other prestigious agencies and foundations with early-stage awards to large, multi-phase funding for major projects. Rowan faculty-researchers have made significant discoveries and progress in therapies for neurological disorders including ALS, Parkinson’s and Canavan diseases, moving toward earlier diagnosis, more effective therapies and improved outcomes for people of all ages. Our biomedical engineers are introducing new medical devices, research methods and technology, giving physicians better tools to improve patient health.   

The Rowan-Virtua partnership promises to further distinguish South Jersey as a regional hub for innovation, research and clinical discovery as it expands through the developing School of Translational Biomedical Engineering & Sciences. With support from the Virtua Health endowment, the school is recruiting 50 new faculty investigators, including basic and clinician scientists, over the next decade. 

Three new institutes will research vital concerns in:

Continuing Rowan’s commitment to attract, support and develop researchers, the school will welcome students to its teams at every level and throughout its disciplines. 
  

Investing in visionary ideas

Furthering Rowan University’s commitment to a robust South Jersey economy, the Rowan University Foundation recently expanded its venture capital fund to $25 million, creating more opportunities to support applied research, especially in healthcare-related innovation. The fund’s expansion further supports the Rowan-Virtua commitment to create a dynamic and transformational academic health system driving innovation and advancing clinical care.

Launched with $5 million in 2014, the Rowan Innovation Venture Fund continues to invest in visionary ideas to back a pipeline of evolving businesses from within and outside the Rowan University community. To date, the fund has provided more than $2.4 million to life sciences companies, with more funding on the horizon as Rowan-Virtua teams accelerate and broaden their research.